Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Sponsor: ECOG- ACRIN
Enrolling: Male and Female Patients
IRB Number: AAAP9159
U.S. Govt. ID: NCT02465060
Contact: Research Nurse Navigator: 212-342-5162 /
Additional Study Information: To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas (including breast cancer, esophageal cancer, lung cancer, sarcomas - bone and soft tissue), thyroid cancer, cervical cancer, ovarian cancer, Hodgkin's disease, non-Hodgkin's lymphoma, pancreatic cancer, colon and rectal cancer, head and neck cancers, skin cancers, melanoma, prostate cancer, and testicular cancer).
This study is closed
Richard Carvajal, MD
Do You Qualify?
Are you 18 years of age or older? Yes No
Do you have advanced refractory cancer/lymphoma? (listed in summary) Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Research Nurse Navigator